Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer

NCT04115163 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

67

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Pancreatic Adenocarcinoma
Stage IV Pancreatic Cancer AJCC v8

Interventions

DRUG: Gemcitabine
DRUG: Nab-paclitaxel

Sponsor

Anne Noonan